NiKem Research

Business Services · Italy · 51-200 Employees

View Company Info for Free

Overview

Headquarters

Via Zambeletti 25, Baranzate, Lombardy, ...

Revenue

$20.1 Million

Industry

Business Services Research & Development
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1

About NiKem Research

Based on decades of pharmaceutical chemistry research experience and now operating at small company speed, NiKem Research (spin-off of GSK) based at Milan, Italy, offers a full range of medicinal and combinatorial chemistry services and products to the pharmaceutical industry. In addition to expertise in lead optimization and hit validation, NiKem Research offers their CoMergeTM Arrays and Double DiversityTM Arrays, which are screening libraries of highest quality and diversity meant for efficient lead generation assays. NiKem Medicinal Chemistry team has an excellent track record of success and worldwide reputation in various therapeutic fields, e.g. opioid and neurokinin receptors, and vacuolar ATPase research.Explore more
NiKem Research's Social MediaPopular SearchesNikem Research SrlNikem ResearchSIC Code 87,873NAICS Code 54,541Show more

Is NiKem Research your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

NiKem Research is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

NiKem Research is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NiKem Research.

NiKem Research Tech Stack

A closer look at the technologies used by NiKem Research

Top Business Services Companies

Frequently Asked Questions Regarding NiKem Research

What is NiKem Research's official website?
NiKem Research's official website is www.nikemresearch.com
What is NiKem Research's Revenue?
NiKem Research's revenue is $20.1 Million
What is NiKem Research's SIC code?
NiKem Research's SIC: 87,873
What is NiKem Research's NAICS code?
NiKem Research's NAICS: 54,541
How many employees does NiKem Research have?
NiKem Research has 51-200 employees
What industry does NiKem Research belong to?
NiKem Research is in the industry of: Business Services, Research & Development
What technology does NiKem Research use?
Some of the popular technologies that NiKem Research uses are: Microsoft IIS, WordPress.org, reCAPTCHA, PHP
What does NiKem Research do?

Based on decades of pharmaceutical chemistry research experience and now operating at small company speed, NiKem Research (spin-off of GSK) based at Milan, Italy, offers a full range of medicinal and combinatorial chemistry services and products to the pharmaceutical industry. In addition to expertise in lead optimization and hit validation, NiKem... Research offers their CoMergeTM Arrays and Double DiversityTM Arrays, which are screening libraries of highest quality and diversity meant for efficient lead generation assays. NiKem Medicinal Chemistry team has an excellent track record of success and worldwide reputation in various therapeutic fields, e.g. opioid and neurokinin receptors, and vacuolar ATPase research.Read More

What are NiKem Research social media links?
NiKem Research Linkedin page
Is NiKem Research a public company?
NiKem Research is private company therefore does not currently have an official ticker symbol
See more information about NiKem Research

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.